Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BioNTech SEADS(BNTX) | 0 | 682,148 | +682,148 | $0 | $67.06M | 13.04% | +$67.06M |
| Royalty Pharma plcCL A(RPRX) | 0 | 974,412 | +974,412 | $0 | $56.87M | 11.06% | +$56.87M |
| Insmed Incorporated(INSM) | 0 | 496,047 | +496,047 | $0 | $56.62M | 11.01% | +$56.62M |
| Roivant Sciences Ltd.SHS(ROIV) | 0 | 1,472,808 | +1,472,808 | $0 | $53.86M | 10.48% | +$53.86M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 1,087,142 | +1,087,142 | $0 | $48.54M | 9.44% | +$48.54M |
| argenx SEADR(ARGX) | 0 | 37,597 | +37,597 | $0 | $36.05M | 7.01% | +$36.05M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 0 | 40,661 | +40,661 | $0 | $30.83M | 6.00% | +$30.83M |
| Natera, Inc.(NTRA) | 0 | 63,200 | +63,200 | $0 | $26.12M | 5.08% | +$26.12M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 219,183 | +219,183 | $0 | $21.70M | 4.22% | +$21.70M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 628,274 | +628,274 | $0 | $20.29M | 3.95% | +$20.29M |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 695,152 | +695,152 | $0 | $17.47M | 3.40% | +$17.47M |
| Legend Biotech CorporationADS(LEGN) | 0 | 828,880 | +828,880 | $0 | $16.49M | 3.21% | +$16.49M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 0 | 229,300 | +229,300 | $0 | $15.01M | 2.92% | +$15.01M |
| Eli Lilly and Company(LLY) | 0 | 12,600 | +12,600 | $0 | $14.58M | 2.84% | +$14.58M |
| Generate Biomedicines, Inc.(GENB) | 0 | 824,679 | +824,679 | $0 | $12.39M | 2.41% | +$12.39M |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 560,710 | +560,710 | $0 | $11.55M | 2.25% | +$11.55M |
| Avalo Therapeutics Inc | 0 | 564,441 | +564,441 | $0 | $8.65M | 1.68% | +$8.65M |